The TME of NSCLC comprises diverse immune cell populations, including CD8 + cytotoxic T cells, CD4 + helper T cells, Tregs, tumor-associated macrophages (TAMs), and dendritic cells (DCs) (31). This evidence concerns the gene CD8A and non-small cell lung carcinoma.